HIGHLIGHTS
- who: Takayuki Hori from the (UNIVERSITY) have published the paper: Successful cases of percutaneous left ventricular assist device u201cImpellau201d to fulminant myocarditis, in the Journal: (JOURNAL)
- what: Our findings regarding three cases of Impella treatment to patients with FM indicate that the proper selection of Impella devices according to BSA measurements may help to improve clinical outcomes of severe heart failure including FM.
SUMMARY
Due to unstable vital signs under high doses of inotropic agents, Impella CP (assist flow: 2.439 L/min/m2) was implanted to the right femoral artery . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.